ElectroKare
ElectroKare provides AI infrastructure for medical institutions and physicians, built on a signal the body already produces.
Competitive Advantages
ElectroKare reads from a signal the patient already produces, with no draw, no dye, and no added procedure.
Against the alternative of one vendor per question, ElectroKare delivers structural, functional, and biochemical reads from one acquisition. Each read is validated on its own study, with academic partners, and carries its own regulatory status.
Source: clinical.electrokare.com
Growth Drivers
ElectroKare's membership approach centers on continuous performance insights delivered in every session, using the gear a member already owns rather than requiring a new device purchase. The platform works with compatible heart rate straps, so a member does not need to buy new hardware to access the service.
ElectroKare has already found an audience for this offer, with more than 37,000 high performers joined.
Source: performance.electrokare.com
Risk Factors
ElectroKare's regulatory path shapes its approach: getting FDA approval proved too difficult while the startup was still small, so the company shifted its audience.
ElectroKare differentiates itself through its data strategy: medical data is difficult to acquire because of laws governing confidentiality, and the company is currently using open-source data to build ElectroKare.
Source: economics.illinois.edu
Product Overview
ElectroKare builds AI infrastructure for precision, preventative medicine, and human performance, starting with the ECG, and it reads the body from a signal it already produces.
ElectroKare's model is built to read the consequential changes in the body that had not been measured non-invasively before, such as a left ventricle losing strength or a potassium level rising over two days.
Source: electrokare.com